21世纪子痫
综述汇总子痫的流行病学、发病机制、影像学表现、鉴别诊断及产前产后阶梯式管理,并提供预防子痫抽搐的现有推荐。发达国家子痫发生率1.6-10/万,发展中国家50-151/万;未用硫酸镁的重度子痫前期患者抽搐发生率2%,使用硫酸镁者<0.6%。
要点
- 发达国家子痫发生率1.6-10/万,发展中国家50-151/万,后者孕产妇及围产儿死亡率与发病率更高。
- 未接受硫酸镁的重度子痫前期患者子痫抽搐发生率为2%,接受硫酸镁者<0.6%。
- 子痫抽搐处理包括支持治疗防严重损伤、硫酸镁防复发及促进分娩。
核心结论
- 子痫与孕产妇死亡及胎盘早剥、弥散性血管内凝血、肺水肿、吸入性肺炎、心肺骤停、急性肾衰竭等发病率升高相关。
- 子痫抽搐病史可能与多年后长期心血管风险及记忆和注意力相关的认知困难有关。
- 有限数据提示子痫前期孕妇的胎盘生长因子水平在预测不良妊娠结局方面优于临床标志物,该数据可能在未来的研究中外推至子痫的预测。
研究设计与样本
- 本文为综述,汇总现有证据及专家意见,涵盖子痫的可能发病机制、影像学表现、鉴别诊断、产前产后阶梯式管理及子痫抽搐预防的当前推荐。
主要发现
- 发达国家报告的子痫发生率为1.6-10/万次分娩,发展中国家为50-151/万次分娩。
- 未接受硫酸镁的重度子痫前期孕妇中子痫抽搐发生率为2%,接受硫酸镁者<0.6%。
- 子痫抽搐发病机制尚未充分了解,血脑屏障破坏致液体、离子和血浆蛋白进入脑实质仍是主要理论。
- 新数据提示子痫前期孕妇血浆中的循环因子如血管内皮生长因子和胎盘生长因子可能增加血脑屏障通透性。
- 大多数后部可逆性脑病综合征患者的影像学表现将在1-2周内完全消退。
关键数值与推荐
- 子痫抽搐的经典影像学表现为后部可逆性脑病综合征。
- 子痫抽搐后不推荐常规影像学检查,除非有颅内出血、梗死或持续神经功能缺损。
- 常规影像学随访不必要,除非有颅内出血、梗死或持续神经功能缺损。
临床怎么用
- 子痫抽搐的管理包括支持治疗以预防严重母体损伤、硫酸镁预防抽搐复发及促进分娩。
- 需要为重度子痫前期患者制定预防子痫的清晰方案,并在各级医疗保健机构中制定子痫抽搐的急性处理方案。
局限性
- 子痫抽搐的发病机制尚未充分了解。
- 关于胎盘生长因子预测子痫的数据有限,仅为提示性,需在未来研究中外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The reported incidence of eclampsia is 1.6 to 10 per 10,000 deliveries in developed countries, whereas it is 50 to 151 per 10,000 deliveries in developing countries. In addition, low-resource countries have substantially higher rates of maternal and perinatal mortalities and morbidities. This disparity in incidence and pregnancy outcomes may be related to universal access to prenatal care, early detection of preeclampsia, timely delivery, and availability of healthcare resources in developed countries compared to developing countries. Because of its infrequency in developed countries, many obstetrical providers and maternity units have minimal to no experience in the acute management of eclampsia and its complications. Therefore, clear protocols for prevention of eclampsia in those with severe preeclampsia and acute treatment of eclamptic seizures at all levels of healthcare are required for better maternal and neonatal outcomes. Eclamptic seizure will occur in 2% of women with preeclampsia with severe features who are not receiving magnesium sulfate and in <0.6% in those receiving magnesium sulfate. The pathogenesis of an eclamptic seizure is not well understood; however, the blood-brain barrier disruption with the passage of fluid, ions, and plasma protein into the brain parenchyma remains the leading theory. New data suggest that blood-brain barrier permeability may increase by circulating factors found in preeclamptic women plasma, such as vascular endothelial growth factor and placental growth factor. The management of an eclamptic seizure will include supportive care to prevent serious maternal injury, magnesium sulfate for prevention of recurrent seizures, and promoting delivery. Although routine imagining following an eclamptic seizure is not recommended, the classic finding is referred to as the posterior reversible encephalopathy syndrome. Most patients with posterior reversible encephalopathy syndrome will show complete resolution of the imaging finding within 1 to 2 weeks, but routine imaging follow-up is unnecessary unless there are findings of intracranial hemorrhage, infraction, or ongoing neurologic deficit. Eclampsia is associated with increased risk of maternal mortality and morbidity, such as placental abruption, disseminated intravascular coagulation, pulmonary edema, aspiration pneumonia, cardiopulmonary arrest, and acute renal failure. Furthermore, a history of eclamptic seizures may be related to long-term cardiovascular risk and cognitive difficulties related to memory and concentration years after the index pregnancy. Finally, limited data suggest that placental growth factor levels in women with preeclampsia are superior to clinical markers in prediction of adverse pregnancy outcomes. This data may be extrapolated to the prediction of eclampsia in future studies. This summary of available evidence provides data and expert opinion on possible pathogenesis of eclampsia, imaging findings, differential diagnosis, and stepwise approach regarding the management of eclampsia before delivery and after delivery as well as current recommendations for the prevention of eclamptic seizures in women with preeclampsia.
引用
- Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2020. PMID: 32980358. doi:10.1016/j.ajog.2020.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。